The epidemiology of preterm labour—why have advances not equated to reduced incidence?
The cost of preterm birth: the low cost versus high value of tocolysis
EPICure: facts and figures: why preterm labour should be treated
Management of the neonate at the limits of viability: the Dutch viewpoint
The preterm parturition syndrome
The role of inflammation in preterm birth—focus on periodontitis
Aetiology of preterm labour: bacterial vaginosis
Preterm birth: the value of sonographic measurement of cervical length
Should every unit have a 24-hour transvaginal ultrasound available?
Diagnosis of early preterm labour
Does assisted reproduction technology, per se , increase the risk of preterm birth?
Use of tocolytics: what is the benefit of gaining 48 hours for the fetus?
Use of tocolytics: what is the benefit of gaining even more time?
Mode of delivery in the early preterm infant (<28 weeks)
Setting up a preterm prevention clinic: a practical guide
The quality of randomised trials of tocolysis
A quality assessment tool to evaluate tocolytic studies
Regulatory and methodologic challenges to tocolytic development
Clinical practice evaluation of atosiban in preterm labour management in six European countries
Continuing challenges in treating preterm labour: preterm prelabour rupture of the membranes
Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers
‘Normal’ pregnancy with adverse events on initial tocolytic treatment
The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome
Prematurity or immaturity?